238
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Mild hyperthermia with magnetic resonance- guided high intensity focused ultrasound combined with salvage chemoradiation for recurrent rectal cancer

, , , , , , , , , , & show all
Article: 2365385 | Received 01 Sep 2023, Accepted 03 Jun 2024, Published online: 19 Jun 2024

References

  • Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: cancer Today. Lyon International Agency for Research on Cancer; 2020.
  • Enríquez-Navascués JM, Borda N, Lizerazu A, et al. Patterns of local recurrence in rectal cancer after a multidisciplinary approach. World J Gastroenterol. 2011;17(13):1–11. doi: 10.3748/wjg.v17.i13.1674.
  • Cottet V, Bouvier V, Rollot F, et al. Incidence and patterns of late recurrences in rectal cancer patients. Ann Surg Oncol. 2015;22(2):520–527. doi: 10.1245/s10434-014-3990-1.
  • Guren MG, Undseth C, Rekstad BL, et al. Reirradiation of locally recurrent rectal cancer: a systematic review. Radiother Oncol. 2014;113(2):151–157. doi: 10.1016/j.radonc.2014.11.021.
  • Ng MK, Leong T, Heriot AG, et al. Once-daily reirradiation for rectal cancer in patients who have received previous pelvic radiotherapy. J Med Imaging Radiat Oncol. 2013;57(4):512–518. doi: 10.1111/1754-9485.12057.
  • Sun DS, Zhang JD, Li L, et al. Accelerated hyperfractionation field involved re-irradiation combined with concurrent capecitabine chemotherapy for locally recurrent and irresectable rectal cancer. Br J Radiol. 2012;85(1011):259–264. doi: 10.1259/bjr/28173562.
  • Koom WS, Choi Y, Shim SJ, et al. Reirradiation to the pelvis for recurrent rectal cancer. J Surg Oncol. 2012;105:637–642.
  • Kampinga HH, Dikomey E. Hyperthermic radiosensitization: mode of action and clinical relevance. Int J Radiat Biol. 2001;77(4):399–408. doi: 10.1080/09553000010024687.
  • Landon C, Park JY, Needham D, et al. Nanoscale drug delivery and hyperthermia: the materials design and preclinical and clinical testing of low temperature-sensitive liposomes used in combination with mild hyperthermia in the treatment of local cancer. Open Nanomed J. 2011;3(1):38–64. doi: 10.2174/1875933501103010038.
  • Lyon P, Gray M, Mannaris C, et al. Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial. The Lancet Oncology. 2018;19(8):1027–1039. doi: 10.1016/S1470-2045(18)30332-2.
  • Rolf ID. Hyperthermia adds to chemotherapy. Eur J Cancer. 2008;44(17):2546–2554. doi: 10.1016/j.ejca.2008.07.038.
  • Van der Zee J, González D. The Dutch deep hyperthermia trial: results in cervical cancer. Int J Hyperthermia. 2011;18(1):1–12.
  • Vernon C, Hand JW, Field S, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. international collaborative hyperthermia group. Int J Radiat Oncol, Biology, Physics. 2011;35(4):731–744.
  • Huilgol NG, Gupta S, Sridhar CR. Hyperthermia with radiation in the treatment of locally advanced head and neck cancer: a report of randomized trial. J Cancer Res Ther. 2010;6(4):492–496. doi: 10.4103/0973-1482.77101.
  • Issels RD, Lars HL, Jaap V, et al. Effect of neoadjuvant chemotherapy plus regional hyperthermia on long-term outcomes among patients with localized high-risk soft tissue sarcoma: the EORTC 62961-ESHO 95 randomized clinical trial. JAMA Oncol. 2018;4(4):483–492. doi: 10.1001/jamaoncol.2017.4996.
  • Hurwitz M, Irving D, Jorgen LH, et al. Hyperthermia combined with radiation in treatment of locally advanced prostate cancer is associated with a favourable toxicity profile. int j Hyperthermia. 2005;21(7):649–656. doi: 10.1080/02656730500331967.
  • Guillemin PC, Sinden D, M’Rad Y, et al. A novel concept of transperineal focused ultrasound transducer for prostate cancer local deep hyperthermia treatments. Cancers. 2022; 15(1):163. doi: 10.3390/cancers15010163.
  • Van Valenberg H, Colombo R, Witjes F. Intravesical radiofrequency-induced hyperthermia combined with chemotherapy for non-muscle-invasive bladder cancer. Int J Hyperthermia. 2016;32(4):351–362. doi: 10.3109/02656736.2016.1140232.
  • Chu W, Staruch RM, Pichardo S, et al. Magnetic resonance-guided high-intensity focused ultrasound hyperthermia for recurrent rectal cancer: MR thermometry evaluation and preclinical validation. Int J Radiat Oncol Biol Phys. 2016;95(4):1259–1267. doi: 10.1016/j.ijrobp.2016.03.019.
  • Guillemin PC, Gui L, Lorton O, et al. Mild hyperthermia by MR-guided focused ultrasound in an ex vivo model of osteolytic bone tumour: optimization of the spatio-temporal control of the delivered temperature. J Transl Med. 2019;17(1):350. doi: 10.1186/s12967-019-2094-x.
  • Zhu L, et al. Characterization of magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU)-induced large-volume hyperthermia in deep and superficial targets in a porcine model. Int J Hyperthermia. 2020;37(1):1159–1173.
  • Zhu L, et al. Feasibility and safety assessment of magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU)-mediated mild hyperthermia in pelvic targets evaluated using an in vivo porcine model. Int J Hyperthermia. 2019;36(1):1147–1159.
  • Tillander M, Steffen H, Julius K, et al. High intensity focused ultrasound induced in vivo large volume hyperthermia under 3D MRI temperature control. Med Phys. 2016;43(3):1539–1549. doi: 10.1118/1.4942378.
  • Berdov BA, Menteshashvili GZ. Thermoradiotherapy of patients with locally advanced carcinoma of the rectum. Int J Hyperthermia. 1990; 6(5):881–890. doi: 10.3109/02656739009140970.
  • Rau B, Wust P, Hohenberger P, et al. Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trial. Ann Surg. 1998;227(3):380–389. doi: 10.1097/00000658-199803000-00010.
  • Wust P, Rau B, Gellerman J, et al. Radiochemotherapy and hyperthermia in the treatment of rectal cancer. Recent Results Cancer Res. 1998;146:175–191. doi: 10.1007/978-3-642-71967-7_16.
  • Kang MK, Kim MS, Kim JH. Clinical outcomes of mild hyperthermia for locally advanced rectal cancer treated with preoperative radiochemotherapy. Int J Hyperthermia. 2011;27(5):482–490. doi: 10.3109/02656736.2011.563769.
  • Milani V, Pazos M, Issels RD, et al. Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer. Strahlenther Onkol. 2008;184(3):163–168. doi: 10.1007/s00066-008-1731-8.
  • Schaffer M, Krych M, Pachmann S, et al. Feasibility and morbidity of combined hyperthermia and radiochemotherapy in recurrent rectal cancer–preliminary results. Onkologie. 2003;26(2):120–124. doi: 10.1159/000069830.
  • De Haas-Kock DF, Buijsen J, Pijls-Johannesma M, et al. Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer. Cochrane Database Syst Rev. 2009;3(3):CD006269. doi: 10.1002/14651858.CD006269.pub2.
  • van der Valk MJM, Hilling DE, Bastiaannet E, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391(10139):2537–2545. doi: 10.1016/S0140-6736(18)31078-X.
  • Kim H, Pedersen K, Olsen JR, et al. Nonoperative rectal cancer management with short-course radiation followed by chemotherapy: a nonrandomized control trial. Clin Colorectal Cancer. 2021;20(3):e185–e193. doi: 10.1016/j.clcc.2021.03.003.
  • Garcia Aguilar J, Patil S, Kim JK, et al. Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial. J Clin Oncol. 2020;38(15_suppl):4008–4008. doi: 10.1200/JCO.2020.38.15_suppl.4008.
  • You YN, Hardiman KM, Bafford A, et al. The American Society of colon and rectal surgeons clinical practice guidelines for the management of rectal cancer. Dis Colon Rectum. 2020;63(9):1191–1222. doi: 10.1097/DCR.0000000000001762.
  • National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology. https://www.nccn.org/professionals/physician_gls.
  • Bahadoer RR, Dijkstra EA, van Etten B, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(1):29–42. doi: 10.1016/S1470-2045(20)30555-6.
  • Jin J, Tang Y, Hu C, et al. Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR). J Clin Oncol. 2022;40(15):1681–1692.
  • Conroy T, Bosset JF, Etienne PL, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(5):702–715. May doi: 10.1016/S1470-2045(21)00079-6.
  • Gani C, Lamprecht U, Ziegler A, et al. Deep regional hyperthermia with preoperative radiochemotherapy in locally advanced rectal cancer, a prospective phase II trial. Radiother Oncol. 2021;159:155–160. doi: 10.1016/j.radonc.2021.03.011.